This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

AOP: 567

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

Binding to plastoquinone B site leading to decreased population growth rate via photosystem II inhibition

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
Qb protein binding leading to decrease, population growth via PSII inhibition
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.7

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • Li Xie
  • Knut Erik Tollefsen

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on February 04, 2026 04:53

Revision dates for related pages

Page Revision Date/Time
Binding of plastoquinone B (QB) within D1 protein of Photosystem II February 04, 2026 06:58
Decrease, Photosystem II efficiency January 16, 2026 04:26
Decrease, Photosynthesis January 20, 2026 03:44
Decreased, mitochondrial oxidative phosphorylation February 04, 2026 03:52
Decrease, ATP production February 04, 2026 05:16
Decrease, Population growth rate January 03, 2023 09:09
Binding to the QB site D1 protein leads to Decrease, Photosystem II efficiency February 04, 2026 08:47
Decrease, Photosystem II efficiency leads to Decrease, Photosynthesis April 11, 2021 08:25
Decrease, Photosynthesis leads to Decrease in mitochondrial oxidative phosphorylation August 05, 2025 07:27
Decrease, ATP production leads to Decrease, Population growth rate August 05, 2025 07:27
Decrease in mitochondrial oxidative phosphorylation leads to Decrease, ATP production August 05, 2025 07:27
Diuron May 24, 2018 15:29

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

Photosystem II (PSII) is essential for photosynthesis in primary producers, facilitating the primary photochemical reaction to oxidize water and drive the production of ATP and NADPH. A critical interaction within PSII occurs at the plastoquinone B (QB) site on the D1 protein, where electron transfer from QA to QB ensures the continuity of photosynthetic electron flow and energy transduction. PSII-inhibitors can competitively bind to this QB site, blocking electron flow and suppressing the production of ATP and NADPH in chloroplasts. This disruption constrains downstream processes at different biological levels and consequently result in growth inhibition. PSII inhibitors are frequently detected in surface and ground waters, especially in agricultural regions. Their prolonged mobility results in chronic exposure of non-target organisms, particularly primary producers such as algae, aquatic macrophytes, and terrestrial plants that share conserved QB binding sites with target weeds. To improve mechanistic understanding and strengthen ecological risk assessment of PSII-inhibitor, such as herbicides, AOP #567 was developed. This AOP delineates a linear cascade of key events, beginning with the binding of PSII inhibitors to the QB site on the D1 protein, leading through successive reductions in PSII efficiency, photosynthesis, mitochondrial OXPHOS, and ATP production, and culminating in decreased growth rates of primary producer populations. By systematically linking molecular interactions to population-level outcomes, AOP #567 provides a transparent and biologically plausible framework to assess the environmental hazards posed by PSII inhibitors.

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 2307 Binding of plastoquinone B (QB) within D1 protein of Photosystem II Binding to the QB site D1 protein
KE 1862 Decrease, Photosystem II efficiency Decrease, Photosystem II efficiency
KE 1475 Decrease, Photosynthesis Decrease, Photosynthesis
KE 1545 Decreased, mitochondrial oxidative phosphorylation Decrease in mitochondrial oxidative phosphorylation
KE 1472 Decrease, ATP production Decrease, ATP production
AO 360 Decrease, Population growth rate Decrease, Population growth rate

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help
Name
Diuron

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help
Life stage Evidence
All life stages High

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help
Term Scientific Term Evidence Link
Lemna minor Lemna minor High NCBI
Arabidopsis thaliana Arabidopsis thaliana High NCBI
Chlamydomonas reinhardtii Chlamydomonas reinhardtii High NCBI

Sex Applicability

The sex for which the AOP is known to be applicable. More help
Sex Evidence
Unspecific High

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

The present AOPdescribes the potential causal events initiated by the binding of photosystem II (PSII) inhibitors to the plastoquinone B (QB) site of the D1 protein within the PSII complex (MIE, event 1975), leading to a decrease in population growth rate in primary producers (adverse outcome, event 2181) via a cascade of intermediate key events (KEs), including inhibition of PSII electron transport (event 1976), decrease in PSII efficiency (event 1977), and ultimately, decrease in growth rate (event 2031). The Table 1 provides a summary of  the KEs that constitute the AOP and the representative methods for measurement of each KE. 

The MIE constitutes the competitive binding of PSII inhibitors to the QB site, which disrupts the transfer of electrons between QA and QB. This blockage has a direct inhibitory impact on the functioning of the PSII complex and causes the first downstream KE: the inhibition of PSII efficiency, which is typically reported as Fv/Fm ratio or ΦPSII. The lower PSII efficiency is an indication of reduced energy conversion in the light-dependent components of photosynthesis. As a logical physiological consequence, this leads to a decrease in carbon fixation and the availability of ATP and NADPH, both of which are essential for cellular growth. here is a consequent decrease in the rate of organismal growth, particularly on the taxa that grows fast like phytoplankton and aquatic plants.

This series of KEs represents the minimal essential path of causally linked events required to describe how a molecular-level interaction with a chemical stressor produces an ecologically relevant adverse outcome. Each KE and its connection to the adjacent events are evidenced by the mechanistic and empirical evidence, dose-response relationships, as well as taxonomic concordance, as it is elaborated in the section “Summary of scientific evidence assessment” below. Although the subsequent secondary effects, such as oxidative stress and thylakoid membrane damage, also can happen after the PSII disruption, they do not constitute a necessary part of this AOP but rather play a modifying role. The mechanisms of the reactions discussed are very well conserved and the events are consequently found in very wide range of photosynthetic organisms i.e. algae, cyanobacteria, and aquatic vascular plants. This linear AOP can be included in a network of herbicide-related inhibition of photosynthesis and downstream effects at the population level that can occur across primary producers.

Table 1. Summary of key events in AOP #567 and related measurement methods

Event ID

Description

Measurement Methods

Reference

2307

Binding of PSII inhibitors to plastoquinone B

In vitro binding assays (radioligand binding, fluorescence-based assays, surface plasmon resonance, isothermal titration calorimetry)

(Battaglino, Grinzato and Pagliano, 2021; Broser et al., 2011; Giardi and Pace, 2006; Piletska, Piletsky and Rouillon, 2006; Tischer and Strotmann, 1977; Zimmermann et al., 2006)

1862

Decrease, photosystem II efficiency

Chlorophyll fluorescence analysis (Fv/Fm ratio), oxygen evolution rates, PAM fluorometry, modulated fluorometry, D1 protein degradation assays

(Alfonso et al., 1996; DELIEU and WALKER, 1981; Maxwell and Johnson, 2000; Xia et al., 2023)

1442

Decrease, photosynthesis

Carbon fixation rates (14C uptake), oxygen production, infrared gas analysis (CO2 uptake), measurement of Rubisco activity,O2 evolution

(Grant and Howard, 1980; Lilley and Walker, 1974; Milligan, Halsey and Behrenfeld, 2015; Sales, da Silva and Carmo-Silva, 2020; van Gorkom and Gast, 1996; Xie et al., 2019)

1545

Decrease, mitochondrial OXPHOS

Respirometry, ATP synthesis rates, enzyme activity assays for complexes I-IV, mitochondrial membrane potential assays, blue-native PAGE

(Coulson, Duffy and Staples, 2024; Djafarzadeh and Jakob, 2017; Hitchins, Cieslar and Dobson, 2001; Lundin, Rickardsson and Thore, 1976; Xie et al., 2019; Yan and Forster, 2009)

1472

Decrease, ATP production

Luciferase-based ATP assays, enzymatic assays for ATP synthase, NMR spectroscopy, high-performance liquid chromatography (HPLC)

(Allakhverdiev et al., 2005; Coulson, Duffy and Staples, 2024; Hitchins, Cieslar and Dobson, 2001; Juarez-Facio et al., 2021)

360

Decrease, population growth rate

Growth rate calculations from biomass or cell count, specific growth rate in cultures, flow cytometry for cell cycle analysis, optical density measurements

(Peniuk, Schnurr and Allen, 2016; RICHARD, 1971; Xie, Macken and Tollefsen, 2025; Xie et al., 2019). OECD guidelines

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

Evidence for essentiality in an AOP refers to demonstrating that if an upstream key event is prevented or reversed, the subsequent downstream events do not occur (or normal recovery).  In AOP 567, the essentiality of events were determined based on exposure-recovery experiments, the inhibition-rescue experiments as well as the mechanistic studies of aquatic plants and algae. The essentiality of the MIE (Event 2307: Binding of plastoquinone B to the D1 protein) is considered high, since this is the well characterised target site of most PSII-inhibitor herbicides. A number of reports show that the herbicide can be artificially removed or that replacement of the PSII acceptors by oxidants with alternative electron acceptors (e.g., decyl-plastoquinone) will allow restoration of the activity of PSII and avoid downstream consequences on photosynthesis and subsequent growth. Similarly, KE1 (Event 1862: Decrease in PSII efficiency) is also considered high in essentiality. Inhibition of PSII activity directly results in reduced quantum yield and electron transport, and restoration of PSII activity has been consistently associated with recovery of photosynthetic performance. There is strong empirical evidence showing that PSII efficiency (e.g., Fv/Fm, ΦPSII) strongly correlates with primary productivity in photosynthetic organisms. And recovery study on seagrass after exoposure to diuron indicated the ΔF/Fm and growth rate returned over few weeks after removal to clean water. The KE2 (Event 1472: Decrease in photosynthesis) is assigned to high essentiality as well. Studies in both algae and aquatic plants have shown that when photosynthesis is suppressed, growth rapidly declines, and normal function resumes when photosynthetic activity is restored. In contrast, KE3 (Event 1545: Decrease in mitochondrial oxidative phosphorylation) is considered to have moderate essentiality. While evidence indicates that mitochondrial ATP production is reduced following photosynthetic inhibition due to limited carbohydrate substrate availability, the capacity for partial compensation through glycolysis or alternative pathways reduces the strength of causal inference. Finally, KE4 (Event 1472: Decrease in ATP production) also holds moderate essentiality. Growth inhibition is mechanistically connected to a lack of ATP. However, few direct rescue studies, using ATP precursors or supply of energy, provide uncertainty. 

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

References

List of the literature that was cited for this AOP. More help